Fisher & Paykel Healthcare executive adjusts shareholdings

Justin Peter Callahan, vice president - sales & marketing at Fisher & Paykel Healthcare Corporation Limited, has adjusted his relevant interests in the company, as detailed in an ongoing disclosure notice dated September 18, 2025. This follows a previous disclosure on September 5, 2025.

Callahan's holdings now stand at 103,960 options to acquire ordinary shares (down from 135,110), 64,091 performance share rights (down from 77,819), and 220,467 ordinary shares (up from 213,210). The increase in ordinary shares includes 44,839 shares held prior to his April 1, 2024, appointment as vice president - sales & marketing, which were previously omitted from disclosures.

The transactions involved the exercise and cancellation of 31,150 options at an exercise price of NZD 19.63, resulting in the issue of 15,107 ordinary shares. Additionally, 13,728 performance share rights were exercised, leading to the issue of 13,728 ordinary shares. Further disposals included the sale of 13,728 ordinary shares at NZD 37.60 and 7,850 ordinary shares at NZD 37.09. These transactions took place between September 12 and September 17, 2025.